CompletedNot Applicable

An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.

Denmark60 participantsStarted 2021-07-05

Plain-language summary

The aim of this study is to determine the onset time, duration of action and effect on intubation conditions of cisatracurium 0.15 mg/kg in elderly patients with age ≥ 80 years and in young patients aged 18 - 40 years.

Who can participate

Age range18 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients ≥ 80 or ≥18 - ≤40 years of age
✓. Informed consent
✓. Scheduled for elective surgery under general anaesthesia (expected duration of anaesthesia \> 1 hour) with intubation and use of cisatracurium
✓. American Society of Anaesthesiologists (ASA) physical status classification I to III
✓. Can read and understand Danish

Exclusion criteria

✕. Known allergy to cisatracurium
✕. Neuromuscular disease
✕. Indication for rapid sequence induction
✕. Surgery in the prone position

What they're measuring

Onset time

Timeframe: within 10 minutes after administration

Trial details

NCT IDNCT04921735

SponsorMatias Vested

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-19

View on ClinicalTrials.gov More Onset Time of Cisatracurium trials